Canlyniadau Chwilio - Wechalekar, Ashutosh D

The Evolving Epidemiology of Amyloidosis gan Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Thoracic amyloidomas: Two case reports of an evasive diagnosis gan Cresner, Rosie, Mahmood, Shameem, Chen, Jane, Rowan, Camilla, Wechalekar, Ashutosh D

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Updates in Cardiac Amyloidosis: A Review gan Banypersad, Sanjay M., Moon, James C., Whelan, Carol, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... gan Wechalekar, Ashutosh D., Gillmore, Julian D., Wassef, Nancy, Lachmann, Helen J., Whelan, Carol, Hawkins, Philip N.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds gan Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Two types of amyloid in a single heart gan Mahmood, Shameem, Gilbertson, Janet A., Rendell, Nigel, Whelan, Carol J., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Gillmore, Julian D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis gan Sharpley, Faye A., Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Fontana, Marianna, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis gan Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria gan Sharpley, Faye A., Fontana, Marianna, Martinez-Naharro, Ana, Manwani, Richa, Mahmood, Shameem, Sachchithanantham, Sajitha, Lachmann, Helen J., Gillmore, Julian D., Whelan, Carol J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis gan Ravichandran, Sriram, Law, Steven, Mahmood, Shameem, Wisniowski, Brenden, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib gan Ravichandran, Sriram, Cohen, Oliver C., Law, Steven, Foard, Darren, Fontana, Marianna, Martinez-Naharro, Ana, Whelan, Carol, Gillmore, Julian D., Lachmann, Helen J., Sachchithanantham, Sajitha, Mahmood, Shameem, Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis gan Rezk, Tamer, Gilbertson, Janet A, Mangione, P Patrizia, Rowczenio, Dorota, Rendell, Nigel B, Canetti, Diana, Lachmann, Helen J, Wechalekar, Ashutosh D, Bass, Paul, Hawkins, Philip N, Bellotti, Vittorio, Taylor, Graham W, Gillmore, Julian D

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A prospective study of nutritional status in immunoglobulin light chain amyloidosis gan Sattianayagam, Prayman T., Lane, Thirusha, Fox, Zoe, Petrie, Aviva, Gibbs, Simon D.J., Pinney, Jennifer H., Risom, Signe S., Rowczenio, Dorota M., Wechalekar, Ashutosh D., Lachmann, Helen J., Gilbertson, Janet A., Hawkins, Philip N., Gillmore, Julian D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis gan Cohen, Oliver C., Law, Steven, Lachmann, Helen J., Sharpley, Faye, Ravichandran, Sriram, Mahmood, Shameem, Sachchithanantham, Sajitha, Whelan, Carol J., De Azcona Naharro, Ana Martinez, Fontana, Marianna, Hawkins, Philip N., Gillmore, Julian D., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis gan Dispenzieri, Angela, Kastritis, Efstathios, Wechalekar, Ashutosh D., Schönland, Stefan O., Kim, Kihyun, Sanchorawala, Vaishali, Landau, Heather J., Kwok, Fiona, Suzuki, Kenshi, Comenzo, Raymond L., Berg, Deborah, Liu, Guohui, Kumar, Arun, Faller, Douglas V., Merlini, Giampaolo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-I gan Rowczenio, Dorota, Dogan, Ahmet, Theis, Jason D., Vrana, Julie A., Lachmann, Helen J., Wechalekar, Ashutosh D., Gilbertson, Janet A., Hunt, Toby, Gibbs, Simon D.J., Sattianayagam, Prayman T., Pinney, Jenny H., Hawkins, Philip N., Gillmore, Julian D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting gan Venner, Christopher P., Gillmore, Julian D., Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer H, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Systemic Amyloidosis in England: an epidemiological study gan Pinney, Jennifer H, Smith, Colette J, Taube, Jessi B, Lachmann, Helen J, Venner, Christopher P, Gibbs, Simon D J, Dungu, Jason, Banypersad, Sanjay M, Wechalekar, Ashutosh D, Whelan, Carol J, Hawkins, Philip N, Gillmore, Julian D

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma gan Lecat, Catherine S. Y., Taube, Jessica B., Wilson, William, Carmichael, Jonathan, Parrish, Christopher, Wallis, Gabriel, Kyriakou, Charalampia, Lee, Lydia, Mahmood, Shameem, Papanikolaou, Xenofon, Rabin, Neil K., Sive, Jonathan, Wechalekar, Ashutosh D., Yong, Kwee, Cook, Gordon, Popat, Rakesh

Cael y testun llawn Cael y testun llawn Cael y testun llawn

T1 mapping and survival in systemic light-chain amyloidosis gan Banypersad, Sanjay M., Fontana, Marianna, Maestrini, Viviana, Sado, Daniel M., Captur, Gabriella, Petrie, Aviva, Piechnik, Stefan K., Whelan, Carol J., Herrey, Anna S., Gillmore, Julian D., Lachmann, Helen J., Wechalekar, Ashutosh D., Hawkins, Philip N., Moon, James C.

Cael y testun llawn Cael y testun llawn Cael y testun llawn